Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy.

Edler, David

Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Apr 2002 - 1721-8 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0732-183X

10.1200/JCO.2002.07.039 doi


Adjuvants, Immunologic--administration & dosage
Aged
Analysis of Variance
Antimetabolites, Antineoplastic--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor--blood
Chemotherapy, Adjuvant
Colorectal Neoplasms--drug therapy
Disease-Free Survival
Drug Administration Schedule
Female
Fluorouracil--administration & dosage
Gene Expression Regulation, Enzymologic
Gene Expression Regulation, Neoplastic
Humans
Immunohistochemistry
Leucovorin--administration & dosage
Levamisole--administration & dosage
Male
Middle Aged
Neoplasm Staging
Predictive Value of Tests
Prognosis
Proportional Hazards Models
Survival Analysis
Thymidylate Synthase--blood
Treatment Outcome